Ketamine is a dissociative anesthetic that blocks certain receptors in the brain, producing a wide range of effects: numbness, detachment from your body, altered perception of time and space, and at higher doses, complete sedation. Originally developed for surgical anesthesia in the 1960s, it’s now also used at much lower doses to treat severe depression. What you experience depends almost entirely on how much you take and how it enters your body.
How It Feels During and After Use
Ketamine’s signature effect is dissociation, a sense of being separated from your own body. At low doses, this can feel like floating, mild detachment, or a dreamlike state where sounds seem distant and time stretches or compresses unpredictably. Colors may appear more vivid, and your surroundings can feel unfamiliar even in a room you know well. Many people describe a feeling of calm or emotional loosening, which is part of why it’s being explored for depression treatment.
At moderate to high doses, the effects intensify considerably. People report feeling as though they’re melting into their surroundings, rising above their body, or being transported to entirely different places. Hallucinations become more likely. Confusion, disorientation, and short-term memory loss are common. Physically, you may feel numb, dizzy, or nauseous, and coordination deteriorates to the point where speaking or moving becomes difficult. Panic and anxiety can surface, especially if the dissociative experience feels overwhelming or unexpected.
At very high doses, particularly with recreational use, people sometimes enter what’s called a “K-hole,” an intense state of near-complete dissociation that can feel like a near-death or out-of-body experience. This is not the same as unconsciousness, but the person is largely unable to interact with the outside world during it.
What It Does to Your Brain
Ketamine works primarily by blocking a receptor called NMDA, which is involved in how brain cells communicate with each other. By temporarily interrupting this signaling, ketamine disrupts the normal flow of sensory information, which is why your perception of sight, sound, touch, and time all shift at once. It also triggers a burst of new connections between brain cells, a process called synaptogenesis, which researchers believe is the mechanism behind its antidepressant effects.
This burst of new neural connections is what sets ketamine apart from traditional antidepressants, which work by gradually adjusting levels of chemical messengers like serotonin. Standard antidepressants typically take weeks to produce noticeable changes. Ketamine, by contrast, can produce measurable mood improvement within two hours of a single dose. One study of patients with treatment-resistant depression found an average drop in depression scores from 31.8 to 12.9 (on a 60-point scale) just two hours after infusion, and a separate study reported a 71% response rate at 24 hours.
Effects on Your Body
Ketamine raises blood pressure and heart rate. A meta-analysis of patients receiving low (sub-anesthetic) doses found an average systolic blood pressure increase of about 13 mmHg, a diastolic increase of roughly 8.5 mmHg, and a heart rate bump of about 4 beats per minute. These changes are modest and temporary in most people, but they’re the reason clinical ketamine sessions involve blood pressure monitoring and why people with uncontrolled high blood pressure or certain heart conditions are typically not candidates for treatment.
Other physical effects include nausea, dizziness, blurred vision, and a sensation of heaviness or numbness in the limbs. At anesthetic doses used in surgery, ketamine suppresses consciousness while maintaining breathing and protective airway reflexes better than many other anesthetics, which is one reason it remains widely used in emergency medicine and in settings where advanced airway equipment isn’t available.
Ketamine for Depression
When used to treat depression, ketamine is given at a fraction of the surgical dose, typically 0.5 mg/kg delivered intravenously over about 40 minutes. A nasal spray version containing esketamine (a more potent mirror-image form of the molecule) is also FDA-approved under the brand name Spravato and is administered in a certified clinic.
Real-world data from 537 patients who completed an induction course of ketamine infusions showed that roughly 54% experienced a significant response (at least a 50% reduction in depression scores) within two to four weeks, and about 29% achieved full remission. These numbers are notable because these patients had treatment-resistant depression, meaning previous medications hadn’t worked. The effects do fade, though, and most protocols involve repeated sessions over several weeks to sustain improvement.
A large randomized trial comparing intravenous ketamine to the esketamine nasal spray in 400 adults with treatment-resistant depression is underway to clarify whether one form works better or is more acceptable to patients. For now, both are used clinically, with the choice often depending on insurance coverage, clinic availability, and individual response.
Risks of Long-Term or Heavy Use
The risk profile changes significantly when ketamine is used frequently over months or years, particularly at recreational doses. Chronic users show measurable impairments in verbal and visual memory and in executive function, the mental processes that help you plan, focus, and switch between tasks. Brain imaging studies have found reduced gray matter volume in the frontal lobes of heavy users, and one study noted that users with the most severe executive dysfunction were the most likely to drop out of detoxification programs, suggesting the cognitive damage itself becomes a barrier to stopping.
The urinary tract takes a particularly hard hit with chronic use. Frequent ketamine use can cause a condition sometimes called “ketamine bladder,” where the bladder lining becomes inflamed and scarred. Symptoms include painful urination, urgency, and in severe cases, a dramatically reduced bladder capacity. Some long-term heavy users have needed surgical intervention. Liver damage and abdominal pain (sometimes called “K-cramps”) are also reported with sustained heavy use.
Psychological dependence is another concern. While ketamine doesn’t produce the same physical withdrawal syndrome as opioids or alcohol, regular users can develop tolerance (needing more to achieve the same effect) and cravings, and the dissociative escape it provides can become psychologically reinforcing.
Medical Use vs. Recreational Use
The gap between clinical and recreational ketamine is wide. In a medical setting, a depression infusion delivers about 35 mg for a 155-pound person over 40 minutes, with vital sign monitoring throughout. Recreational doses vary wildly and are often far higher, especially when tolerance builds. The route matters too: snorting or injecting ketamine produces a faster, more intense onset than a slow intravenous drip, which increases both the intensity of dissociation and the cardiovascular spike.
Surgical anesthesia sits at the other end of the spectrum, with induction doses of 1 to 4.5 mg/kg intravenously or 6.5 to 13 mg/kg intramuscularly. At these levels, ketamine produces complete unconsciousness. The dissociative and hallucinatory effects can surface during emergence from anesthesia, which is why other medications are often given alongside it to smooth the wake-up period.
Context shapes risk. A single low-dose infusion in a monitored clinic carries a very different risk profile than repeated high-dose recreational use. The drug is the same, but the dose, frequency, setting, and supervision change the equation entirely.